Form No number No number MDE Screening and Follow-up

Minimum Data Elements for the National Breast and Cervical Cancer Early Detection Program

OMB_Attachment 03 (MDE60)

Minimum Data Elements/System for Technical Assistance Reporting for the National Breast and Cervical Cancer Early Detection Program

OMB: 0920-0571

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0920-0571 can be found here:

Document [pdf]

Download: pdf | pdf

ATTACHMENT 3
MDE Data Elements and Definitions Required for Reporting

Version 6.0
12/04/2007

OMB Control No. 0920-0571
Expiration Date: 01/31/2010

DATA USER'S MANUAL
for the
National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)
MDE Version 6.0
Proposed Effective Date 01/01/2009

Division of Cancer Prevention and Control
National Center for Chronic Disease Prevention
and Health Promotion
Centers for Disease Control and Prevention
Public reporting burden of this collection of information is estimated to average 4 hours per response, including
the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed,
and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a
person is not required to respond to a collection of information unless it displays a currently valid OMB control
number. Send comments regarding this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road
NE, MS D-24, Atlanta, Georgia 30333; ATTN: PRA (0920-0571).
Version 6.0
12/04/2007

National Breast and Cervical Cancer Early Detection Program
Minimum Data Elements (MDE) Data Definition
Table of Contents:
Section 1

Screening Location ......................................................................................................................................... 2

Section 2

Patient and Record Identification .................................................................................................................... 2

Section 3

Patient Demographic Information .................................................................................................................... 3

Section 4

CBE Screening Information ............................................................................................................................. 4

Section 5

Pap Test Screening Information ...................................................................................................................... 5

Section 6

Initial Mammography Information .................................................................................................................. 10

Section 7

Cervical Diagnostic Procedures .................................................................................................................... 14

Section 8

Cervical Diagnosis Information...................................................................................................................... 15

Section 9

Cervical Cancer Treatment Information ........................................................................................................ 16

Section 10

Breast Imaging Procedures ........................................................................................................................... 17

Section 11

Breast Diagnostic Procedures ....................................................................................................................... 18

Section 12

Breast Final Diagnosis Information ............................................................................................................... 19

Section 13

Breast Cancer Treatment Information ........................................................................................................... 21

Section 14

Cervical Cancer Registry Data ...................................................................................................................... 22

Section 15

Breast Cancer Registry Data......................................................................................................................... 25

Version 6.0
12/04/2007

National Breast and Cervical Cancer Early Detection Program
Minimum Data Elements (MDE) Data Definition
Item Number
New

Column

Old

Variable Name

Length

Begin

End

Codes / Format / Comments

Edit Checks/Skip Patterns

All Patients Section: This section must be completed for each MDE record when NBCCEDP funds are used to pay for all or part of at least one of the screening or diagnostic procedure(s).
1. Screening Location
1.01

State, Territorial, or Tribal
Program

FIPS Code, Right Justify (i.e. California = 6 and Texas = 48,
where  = a blank character.

Valid code for your program.

1.02

County

FIPS Code, Right Justify.

Valid codes for your program.
This is the county of the primary B&C provider.

1.03

Enrollment Site

Right Justify. This should be the point of enrollment of the
woman to the program. The intent is to identify the center that is
administratively responsible for the care and tracking of the
woman.

If Social Security Number (SSN) is used, it must be encoded. The
ID number should be unique and constant for each patient in order
to track the patient over time. This field should not contain any
identifiable information, including partial names or dates.

Valid codes for your sites.

2. Patient and Record Identification
2.01

Unique Patient ID Number

Alphanumeric (no special symbols), left justify.
Alphabetic characters must be entered consistently in
uppercase or lowercase for all records for each patient.
2.02

Record Identifier

Right Justify. This field will be used to uniquely identify one
record among many for a woman. This could be a cycle number, a
visit date, or a record number. In this context, record and
screening cycle have the same meaning.

Version 6.0
12/04/2007

Item Number
New

Old

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

Edit Checks/Skip Patterns

3. Patient Demographic Information
3.01

County of Residence

FIPS Code, Right Justify. (If unknown, blank fill.) Not required if
Zip Code of residence is reported.

Valid FIPS code for the county.

3.02

State or Territory of
Residence

FIPS Code, Right Justify. (If unknown, blank fill.)

Valid FIPS code for the state or territory.

3.03

ZIP Code of Residence

Right Justify. (If unknown, blank fill) Not required if county of
residence is reported.

Valid 5 digit numeric zip code.

3.04

Date of Birth

MMDDYYYY (i.e. Jan 3, 1942 = 01031942). If unknown, blank fill. Check for validity, i.e. no one too old or too young at date
of enrollment. See edit guidelines for dates at the end of
this document.

3.05

Hispanic or Latino Origin
(self reported)

1. Yes
2. No
3. Unknown

Range check.

3.06. 1

3g.1

Race 1
(self reported)

1. White
2. Black or African American
3. Asian
4. Native Hawaiian or Other Pacific Islander
5. American Indian or Alaska Native
7. Unknown
8. Asian/Pacific Islander (v4.1 only)*

Range check. This race field should be populated first. If
a woman self identifies more than one race, then each
race identified should be reported in a separate race field.
Report up to five (5) separate races.

1. White
2. Black or African American
3. Asian
4. Native Hawaiian or Other Pacific Islander
5. American Indian or Alaska Native
7. Unknown

This field should be left blank, unless the woman reports
more than one race.

It is recommended that your Program no longer collect
‘Other’ race on your data collection forms. However, if
your Program collects ’Other‘ as a race category, please
*8 - Asian/Pacific Islander (v4.1 only) may only be reported for data export this to ’7’ (Unknown) in the MDEs.
collected prior to 10/01/2002.
3.06.2

3g.2

Race 2
(self reported)

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

Codes / Format / Comments

Edit Checks/Skip Patterns

3.06.3

3g.3

Race 3
(self reported)

1. White
2. Black or African American
3. Asian
4. Native Hawaiian or Other Pacific Islander
5. American Indian or Alaska Native
7. Unknown

This field should be left blank, unless the woman reports
more than two races.

3.06.4

3g.4

Race 4
(self reported)

1. White
2. Black or African American
3. Asian
4. Native Hawaiian or Other Pacific Islander
5. American Indian or Alaska Native
7. Unknown

This field should be left blank, unless the woman reports
more than three races.

3.06.5

3g.5

Race 5
(self reported)

1. White
2. Black or African American
3. Asian
4. Native Hawaiian or Other Pacific Islander
5. American Indian or Alaska Native
7. Unknown

This field should be left blank, unless the woman reports
more than four races.

4. CBE Screening Information
4.01

Breast Symptoms
(self reported)

1. Yes
2. No
3. Unknown

Range check.

4.02

Clinical Breast Exam

1. Normal/Benign findings - schedule for routine CBE in
one year
2. Abnormality suspicious for cancer - diagnostic evaluation
needed
3. Not needed
4. Needed but not performed at this visit (includes refused)

Range check.

If "Clinical Breast Exam" = ‘1’ or ‘2’, enter MMDDYYYY

If not blank, must be a valid date. Check the skip pattern.
See edit guidelines for skip patterns at the end of this
document.

4.03

Date of Clinical Breast Exam

If "Clinical Breast Exam" = ‘3’ or ‘4’, blank fill.

If the result of this clinical breast exam is ‘2’, the
Additional Breast Procedures Section should be
completed and "Additional Procedures Needed to
Complete Breast Cycle" (6.08) should be ‘1’. Reference
Model Clinical Guidelines in MDE Data User's Manual,
Section 2.

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

4.04

4e.1

Clinical Breast Exam Paid by
NBCCEDP Funds

Codes / Format / Comments
1. Yes
2. No
3. Unknown
If ”Clinical Breast Exam” = ‘3’ or ‘4’, blank fill.

Edit Checks/Skip Patterns
Range and skip pattern check.
If office visit (which includes Clinical Breast Exam) was
paid by NBCCEDP funds, then this field should be set to
‘1’.

5. Pap Test Screening Information
5.01

Previous Pap Test

1. Yes
2. No
3. Unknown

Range check.

5.02

4f.1

Date of Previous Pap Test

If "Previous Pap Test" = ‘1’ then enter MMYYYY (if known) or blank If not blank, must be a valid date. Check the skip pattern.
fill (if unknown).
If "Previous Pap Test" = ‘2’ or ‘3’, blank fill.

Version 6.0
12/04/2007

Item Number
New
5.03

Old

Column
Variable Name

Length

Begin

End

Indication for Pap Test

Codes / Format / Comments
1. Routine Pap test
2. Patient under surveillance for a previous abnormal test.
3. Pap test done by a non-program funded provider, patient
referred in for diagnostic evaluation.
4. Pap test not done. Patient proceeded directly for diagnostic
work-up or HPV test.
5. Breast record only, cervical services not done.
9. Unknown

Edit Checks/Skip Patterns
Range and skip pattern check.
Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
‘1’ (Routine) should be reported for a Pap test performed
as part of a routine screening schedule.
‘2’ (Surveillance) should be reported for a Pap test
performed on a woman under management for a cervical
abnormality detected prior to this cycle.
‘3’ (Referred) should be reported when a patient has had
a Pap test performed outside of the Program, and is
referred to the Program for diagnostic work-up. Referral
Date (5.04) must be completed, and a valid Pap test
Result should be provided: (5.08) “Bethesda 1991” = 1-8,
12 or 14; or (5.09) “Bethesda 2001” = 1-8 or 12.
‘4’ (Not Done) should be reported when the patient does
not have a Pap test and goes directly to HPV testing or
Diagnostic Work-up. Items 5.05 – 5.12 should be blank.
‘5’ (Breast record only) should be reported when no
cervical services are provided or reported in this record,
only breast services. Items 5.05 – 5.16 should be blank.

5.04

Cervical Diagnostic Referral
Date

If “Indication for Pap Test” = “3”, enter MMDDYYYY; otherwise
leave blank

Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
If not blank, must be a valid date. Check the skip pattern.
See edit guidelines for skip patterns at the end of this
document.
This field should indicate the enrollment date for a patient
referred in to the program for diagnostic evaluation
following an abnormal Pap test provided outside of the
program.

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

5.05

Bethesda System Used

Codes / Format / Comments
1. Bethesda 1991
2. Bethesda 2001

Edit Checks/Skip Patterns
Range check.
This field should indicate which Bethesda System was
used to report the Pap test result. If system used is ‘1',
then “Bethesda ’91 Pap test Result” (5.08) should be
completed. If system used is ’2', then “Bethesda ’01 Pap
test Result” (5.09) should be completed.
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘4’ or ‘5’.

5.06

4g.1

Specimen Adequacy of Pap
Test

(For both 1991 and 2001
Bethesda Systems)

1. Satisfactory
2. Satisfactory for evaluation but limited by... (for Bethesda
1991 results only)
3. Unsatisfactory
4. Unknown

Range check.
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘4’ or ‘5’.
For data where Pap test was done prior to 10/01/2002,
this field may be blank. For Pap tests performed after
10/01/2002, this field MUST be completed.
If “Bethesda System Used” (5.05) is ’1' and Specimen
Adequacy is ‘1’, ‘2’ or ‘4’ then “Bethesda ’91 Pap test
Result” (5.08) must be completed. If Specimen Adequacy
is ’3', then “Bethesda ’91 Pap test Result” (5.08) must be
‘8’ (Unsatisfactory).
If “Bethesda System Used” (5.05) is ’2' and Specimen
Adequacy is ‘1’ or ‘4’, then” Bethesda ’01 Pap test Result”
(5.09) must be completed. If Specimen Adequacy is ’3',
then “Bethesda ’01 Pap test Result” (5.09) must be left
blank. A specimen adequacy result of ’2' is NOT VALID for
Bethesda 2001.

5.07

4g.3

Specimen Type for
Pap Test

1. Conventional smear
2. Liquid Based
3. Other
4. Unknown

Range check.
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘4’ or ‘5’.

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

5.08

4g.2

Result of Pap Test

Categories from the
Bethesda 1991 Reporting
System

5.09

4g.4

Result of Pap Test

Categories from the
Bethesda 2001 Reporting
System

5.10

4g.5

Other Pap Test Result

Codes / Format / Comments

Edit Checks/Skip Patterns

Right Justify
1. Negative (within normal limits)
2. Infection/Inflammation/Reactive Changes
3. Atypical squamous cells of undetermined significance
(ASCUS)
4. Low grade SIL (including HPV changes)
5. High grade SIL
6. Squamous Cell Cancer
7. Other
8. Unsatisfactory
11. Result pending
12. Result unknown, presumed abnormal, Pap test from nonprogram funded source
14. Abnormal Glandular Cells (including Atypical Glandular
Cells of Undetermined Significance (AGUS) and
Adenocarcinoma)

Range check.

Right Justify
1. Negative for intraepithelial lesion or malignancy
2. Atypical squamous cells of undetermined significance
(ASC-US)
3. Low grade SIL (including HPV changes)
4. Atypical squamous cells cannot exclude HSIL (ASC-H)
5. High grade SIL (with features suspicious for invasion)
6. Squamous Cell Carcinoma
7. Abnormal Glandular Cells (including Atypical,
Endocervical adenocarcinoma in situ and adenocarcinoma)
8. Other
11. Result pending
12. Result unknown, presumed abnormal, Pap test from nonprogram funded source.

Range check.

This field should be left blank if “Bethesda System Used”
(5.05) is ’2'.
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘4’ or ‘5’.
If the result of this screening Pap test is a ‘5’, ‘6’, ‘12’, or
‘14’ the Additional Cervical Procedures Section MUST be
completed and "Diagnostic work-up planned for cervical
dysplasia or cancer“ (5.16) set to ‘1’. If the result is a ‘3’
or ‘4’ and the clinician chooses to do a diagnostic workup, the Additional Cervical Procedures Section MUST
also be completed and "Diagnostic work-up planned for
cervical dysplasia or cancer" (5.16) set to ‘1’.

This field should be left blank if “Indication for Pap Test”
(5.03) is ‘4’ or ‘5’.
If the result of this Pap test is a ‘4’, ’5’, ‘6’, ‘7’, or ‘12’ the
Additional Cervical Procedures Section MUST be
completed and "Diagnostic work-up planned for cervical
dysplasia or cancer“ (5.16) set to ‘1’. If the result is a ‘1’,
‘2’ or ‘3’ and the clinician chooses to do a diagnostic
work-up, the Additional Cervical Procedures Section
MUST also be completed and "Diagnostic work-up
planned for cervical dysplasia or cancer" (5.16) set to ‘1’.

111 If "Result of Pap Test" = ‘7’ from the 1991 Bethesda, or ‘8’ from the Check the skip pattern.
2001 Bethesda, enter "Result" in free text format.
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘4’ or ‘5’.

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

Codes / Format / Comments

5.11

Date of Pap Test

112

119 For Bethesda 1991:
If "Result of Pap Test" < ‘8’ or ‘14’, enter MMDDYYYY.
If you know the date for ‘11’ or ‘12’, enter MMDDYYYY, otherwise
blank fill.

Edit Checks/Skip Patterns
If not blank, must be a valid date and > “Date of Previous
Pap test” (5.02), if known. Check the skip pattern.
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘4’ or ‘5’.

For Bethesda 2001:
If "Result of Pap Test" < ‘8’, enter MMDDYYYY.
If you know the date for ‘11’ or ‘12’, enter MMDDYYYY, otherwise
blank fill.
5.12

Pap Test Paid by NBCCEDP
Funds

120

120 1. Yes
2. No
3. Unknown
If ”Result of Pap Test“ = ‘11’, and paid data are known, then
enter ‘1’ or '2’. Otherwise blank fill.
If ”Result of Pap Test“ = ‘12’, this field should be set to ‘2’.

5.13

HPV Test Result

121

121 1. Positive
2. Negative
3. Test Not Done
9. Unknown

Range and skip pattern check.
If the Pap test, laboratory services, or pelvic exam were
paid by NBCCEDP funds, then this field should be set to
‘1’ (Yes).
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘4’ or ‘5’.
Range check.
Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘5’.

5.14

Date of HPV Test

122

129 If “HPV Test Result” = ‘1’, ‘2’ or ‘9’, then enter MMDDYYYY
If “HPV Test Result” = ‘3’, blank fill.
Date of HPV Test is the date of the sample collection.

If not blank, must be a valid date. Check the skip pattern.
Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
This field should be left blank if “Indication for Pap Test”
(5.03) is ‘5’.

Version 6.0
12/04/2007

Item Number
New

Old

5.15

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

HPV Test Paid by
NBCCEDP Funds

130

130 1. Yes
2. No
9. Unknown
If “HPV Test Result” = ‘1’, ‘2’ or ‘9’, and paid data are known, then
enter ‘1’ or ‘2’.

5.16

4g.6

Diagnostic Work-up Planned
for Cervical Dysplasia or
Cancer

131

131 1. Diagnostic work-up planned on basis of abnormal Pap test
or pelvic exam
2. Diagnostic work-up not planned
3. Diagnostic work-up plan not yet determined

If “Indication for Pap Test” (5.03) is ‘1’, ‘2’, ‘3’ or ‘4’ this
field must be completed; otherwise, leave blank.
.
The purpose of this field is to indicate the need for
immediate diagnostic work-up. In the vast majority of
cases an abnormal Pap test (defined in 5.08 or 5.09) or
pelvic exam (not collected) will indicate that a diagnostic
work-up is necessary. However, in a small number of
cases a diagnostic work-up will be performed in the
absence of an abnormal Pap test or pelvic exam.
If this field is coded as ‘1’, the Additional Cervical
Procedures Section must be completed. If this field is
coded as ‘2’ or ‘3’, the Additional Cervical Procedures
Section must be blank.

6. Initial Mammography Information
6.01

Previous Mammogram

132

132 1. Yes
2. No
3. Unknown

Range check.

6.02

4j.1

Date of Previous
Mammogram

133

138 If "Previous Mammogram" = ‘1’ then enter MMYYYY (if known) or
blank fill (if unknown).

If not blank, must be a valid date. Check the skip pattern.

If "Previous Mammogram" = ‘2’ or ‘3’ blank fill.

Version 6.0
12/04/2007

Item Number
New
6.03

Old

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

Indication for Initial
Mammogram

139

139 1. Routine screening mammogram
2. Initial mammogram performed to evaluate symptoms, positive
CBE result, or previous abnormal mammogram result
3. Initial mammogram done by a non-program funded provider,
patient referred in for diagnostic evaluation.
4. Initial mammogram not done. Patient only received CBE, or
proceeded directly for other imaging or diagnostic work-up.
5. Cervical record only, breast services not done.
9. Unknown

Edit Checks/Skip Patterns
Range and skip pattern check.
Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
‘1’ (Screening) should be reported for an initial
mammogram performed as part of a routine or annual
screening schedule and in the absence of symptoms or a
recent positive CBE.
‘2’ (Evaluate symptoms) should be reported for an initial
mammogram performed as additional evaluation of a
recent mammogram prior to this cycle, evaluation of
current symptoms or abnormal CBE finding.
‘3’ (Referred) should be reported when a patient has had
a mammogram performed outside of the Program, and is
referred to the Program for diagnostic work-up. Referral
Date (6.04) must be completed, and a valid Mammogram
Result (6.05) of 1 – 7, or 11 should be reported.
‘4’ (Not Done) should be reported when the patient does
not have an initial mammogram performed and goes
directly to Diagnostic Work-up. Items 6.05 – 6.07 should
be blank.
‘5’ (Cervical record only) should be reported when no
breast services are provided or reported in this record,
only cervical services. Initial Mammogram Result (6.05)
should be left blank. Items 6.05 – 6.08 should be blank.

6.04

Breast Diagnostic Referral
Date

140

147 If “Indication for Initial Mammogram” = “3”, enter MMDDYYYY;
otherwise leave blank

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

6.05

Initial Mammography Test
Result

148

149

(includes all mammograms
which were the first
mammogram of a screening
cycle)
Categories from the
American College of
Radiology Breast Imaging
Reporting and Database
System

Codes / Format / Comments
1. Negative (BI-RADS 1)
2. Benign Finding (BI-RADS 2)
3. *Probably Benign – Initial short interval follow-up
suggested (Bi-RADS 3)
4. Suspicious Abnormality - Biopsy should be considered
(BI-RADS 4)
5. Highly Suggestive of Malignancy - Appropriate action
should be taken (BI-RADS 5)
6. Assessment is Incomplete - Need additional imaging
evaluation (BI-RADS 0)
7. Unsatisfactory - This applies if the mammogram was
technically unsatisfactory and could not be interpreted by
radiologist.
10. Result pending
11. Result unknown, presumed abnormal, mammogram from
non-program funded source
13. Film comparison required (BI-RADS 0)
*Based on new BI-RADS guidance from the Fourth Edition 2003,
(3) Probably Benign should not be reported as the initial
mammogram result unless a complete work-up was performed
prior to the screening cycle either within or outside of the program.
Please refer to the Field Description in the Data User’s Manual for
further details.

6.06

6.07

Date of Initial Mammogram

Initial Mammogram Paid by
NBCCEDP Funds

150

158

Edit Checks/Skip Patterns
Range check.
This field should be left blank if “Indication for
Mammogram” (6.03) is ‘4’ or ‘5’.
If the result of the initial mammogram is ‘4’, ‘5’, ‘6’, ‘11’ or
‘13’, the Additional Breast Procedures Section must be
completed and ”Additional procedures needed to
complete breast cycle“ (6.08) should = ‘1’.
A result of ‘7’ (Unsatisfactory) indicates that the cycle
should be considered complete, and a new cycle will
begin with the repeat mammogram.
This variable should be the initial result of the first
mammographic film only. If any additional imaging is
needed, to obtain a final imaging result, then report ‘6’. If
a film comparison is necessary to obtain a final imaging
result, then report ‘13’.

157 If "Initial Mammography Test Result" < ‘7’ or ‘13’ enter
MMDDYYYY.
If you know the date for ‘10’ or ‘11’, enter MMDDYYYY, otherwise
blank fill.

If not blank, must be a valid date and > “Date of Previous
Mammogram” (6.02), if known. Check the skip pattern.

158 1. Yes
2. No
3. Unknown

Range and skip pattern check.

This field should be left blank if “Indication for
Mammogram” (6.03) is ‘4’ or ‘5’.

If ”Initial Mammography Test Result“ = ‘10’ and paid data are
known, then enter a ‘1’ or ‘2’; otherwise blank fill.
If ”Initial Mammography Test Result“ = ‘11’, then this field should
be set to ‘2’.

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

Codes / Format / Comments

6.08

4k.1

Additional Procedures
Needed to Complete Breast
Cycle

159

159 1. Additional procedures needed or planned.
2. Additional procedures not needed or planned.
3. Need or plan for additional procedures not yet determined

Edit Checks/Skip Patterns
If “Indication for Mammogram” (6.03) is ‘1’, ‘2’, ‘3’ or ‘4’
this field must be completed; otherwise, leave blank.
The purpose of this field is to indicate the need or plan for
immediate additional imaging or diagnostic work-up. In
most cases a positive mammogram (defined in 6.05) or
CBE (4.02) will indicate that a diagnostic work-up is
necessary. However, in some cases additional
procedures will be planned in the absence of an abnormal
mammogram or CBE.
If this field is coded as ‘1’, the Additional Breast
Procedures Section must be completed. If this field is
coded as ‘2’ or ‘3’, the Additional Breast Procedures
Section must be blank.

6.09

MDE Version Number

160

161 21.
22.
23.
24.
30.
40.
41.
50.
60.

For data collected through 9/30/1994
For data collected beginning 10/01/1994
For data collected beginning 10/01/1995
For data collected beginning 10/01/1996
For data collected beginning 10/01/1997
For data collected beginning 10/01/1998
For data collected beginning 10/01/1999
For data collected beginning 10/01/2002
For data collected beginning 01/01/2009

Reserved

162

166 Reserved for future use.

The version number is indicated as a footnote to this
document. Note that the period in the version number is
not included. For example, version 5.0 will be submitted
as ‘50’, version 6.0 as ‘60’.

This field should be blank filled.

Version 6.0
12/04/2007

Item Number
New

Old

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

Edit Checks/Skip Patterns

Additional Cervical Procedures Section - This section must be completed if Diagnostic Work-up Planned for Cervical Dysplasia or Cancer (5.16) = ‘1’ (planned), otherwise leave blank.
7. Cervical Diagnostic Procedures
7.01

1a.1

Colposcopy without Biopsy

167

167 1. Yes
2. No

Range check. See edit guideline for range checks at the
end of this document.

7.02

1a.2

Colposcopy with Biopsy
and/or ECC

168

168 1. Yes
2. No

Range check.

Loop Electrosurgical
Excision Procedure (LEEP)

169

169 1. Yes
2. No

Range check.

7.03

Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
7.04

Cold Knife Cone (CKC)

170

170 1. Yes
2. No

Range check.
Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.

7.05

Endocervical Curettage
alone (ECC)

171

171 1. Yes
2. No

Range check.
Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.

7.06

1a.3

Other Cervical Procedures
Performed

172

172 1. Yes
2. No

Range check.

7.07

1a.3

Other Cervical Procedures
Performed Description (from
7.06)

173

212 Free text format, description of "Other Cervical Procedures
Performed".

Check the skip pattern. See edit guideline for skip pattern
checks at the end of this document.

7.08

1a.4

Cervical Diagnostic
Procedures Paid by
NBCCEDP Funds

213

213 1. Yes
2. No
3. Unknown

If at least one cervical diagnostic procedure was paid by
NBCCEDP Funds, then this field should be set to ‘1’.

Version 6.0
12/04/2007

Item Number
New

Old

Column
Variable Name

Codes / Format / Comments

Length

Begin

End

214

214 1. Work-up complete
2. Work-up pending
3. Lost to follow-up
4. Work-up refused
9. Irreconcilable

Edit Checks/Skip Patterns

8. Cervical Diagnosis Information
8.01

Status of Final Diagnosis

Range check.
A status of “Work-up complete” means that the diagnostic
testing is complete, and that “Final Diagnosis” (8.02) and
“Date of Final Diagnosis” (8.04) are known.

A response of “9” will be used for those, which after clinical review;
it is determined that there is no sufficient way to translate the
clinical scenario into the MDE data record. An example would be:
If the clinician refers the woman for short-term follow-up instead of
following the guideline for immediate diagnostic work-up, enter a ‘9’
to indicate a closed cycle with an irreconcilable status.
8.02

Final Diagnosis

215

215 1. Normal/Benign reaction/inflammation
2. HPV/Condylomata/Atypia
3. CINI/mild dysplasia (biopsy diagnosis)
4. CINII/moderate dysplasia (biopsy diagnosis)
5. CINIII/severe dysplasia/Carcinoma in situ (Stage 0) or
Adenocarcinoma In Situ of the cervix (AIS) (biopsy diagnosis)
6. Invasive Cervical Carcinoma (biopsy diagnosis)
7. Other
8. Low grade SIL (biopsy diagnosis)
9. High grade SIL (biopsy diagnosis)

Range check.

Check the skip pattern.

Low grade SIL and High grade SIL are provided as
alternatives to diagnoses 2-5 and only one diagnosis
should be submitted.
Invasive Adenocarcinoma of the cervix should be coded
as a ‘6’ (Invasive Cervical Carcinoma). Adenocarcinoma
In Situ (AIS) of the cervix should be coded as ‘5’
(CIN3/server dysplasia/CIS/AIS).

8.03

1b.7

Final Diagnosis - Other

216

235 Free text format, Description of "Final Diagnosis - Other".

8.04

Date of Final Diagnosis

236

243 If Status of Final Diagnosis (8.01) = ‘1’ enter MMDDYYYY, the date Check the skip pattern. If not blank, should be > “Date of
of diagnosis of cancer or precancerous lesion or date the decision Pap Test” (5.11) in All Patients Section. See edit
made that no cancer present.
guidelines for dates at the end of this document.
If Status of Final Diagnosis (8.01) = ‘2’ then blank fill.
If Status of Final Diagnosis (8.01) = ‘3’, ‘4’ or ‘9’ then enter
MMDDYYYY, the date of administrative closeout.

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

8.05

1b6a

Stage at Diagnosis

244

LEGACY DATA ONLY.
This section is used to
report stage data on all
cancer records with initial
screens prior to 1/1/2004;
or stage data not acquired
through state cancer
registries.

Codes / Format / Comments
If Final Diagnosis (8.02) is a ‘6’ then enter one of the following:
1. Stage I
2. Stage II
3. Stage III
4. Stage IV
5. Summary Local
6. Summary Regional
7. Summary Distant
8. Unknown/Unstaged
If "Final Diagnosis" is NOT a ‘6’, blank fill.

Use Section 14 to report
cancer data acquired
through state cancer
registries for screens
dating from 1/1/2004.

Edit Checks/Skip Patterns
Range and skip pattern check.
This field is not intended for use for cervical screens
beginning 01/01/2009 when it is superseded by Registry
Data fields (14.01 – 14.11). However, it may be optionally
reported, in addition to required registry fields, for data
collected from providers.
If clinical stage is available, report using International
Federation of Gynecology and Obstetrics
(FIGO)/American Joint Committee on Cancer (AJCC),
Fifth Edition, 1997. FIGO/AJCC stage can be reported as
pathological or clinical. FIGO/AJCC clinical stage is
preferred over pathological stage which is preferred over
summary stage.

9. Cervical Cancer Treatment Information – This section is completed based on the results of MDE Item 8.02 (Final Diagnosis).
9.01

Status of Treatment

245

245 If Final Diagnosis (8.02) = ‘4’, ‘5’, ‘6’, or ‘9’ then complete 9.01 and
9.02.
If Final Diagnosis (8.02) = ‘2’, ‘3’, ‘7’, or ‘8’ then 9.01 and 9.02 MAY
be completed.
If Final Diagnosis (8.02) = ‘1’, then 9.01 and 9.02 should be left
blank.
1. Treatment started
2. Treatment pending
3. Lost to follow-up
4. Treatment refused
5. Treatment not needed

A woman should be classified as having started treatment
when the Program has confirmed that a plan for treatment
of the cancer or precancerous lesion has been developed
and started.
Range and skip pattern check.

If a woman dies before treatment has started, enter a ‘3’ (Lost to
follow-up).
9.02

Date of Treatment Status

246

253 If Status of Treatment (9.01) = ‘1’ enter MMDDYYYY, the date that Check the skip pattern. If not blank, should be > “Date of
treatment of cancer or precancerous lesion began.
Final Diagnosis” (8.04).
If Status of Treatment (9.01) = ‘2’ then blank fill.
If Status of Treatment (9.01) = ‘3’, ‘4’, or ‘5’ then enter
MMDDYYYY, the date of administrative closeout.

Reserved

254

258 Reserved for future use.

This field should be blank filled.

Version 6.0
12/04/2007

Item Number
New

Old

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

Edit Checks/Skip Patterns

Additional Breast Procedures Section: This section must be completed if Additional Procedures Needed (6.08) = ‘1’ (Needed/Planned). Otherwise, leave blank.
10. Breast Imaging Procedures
10.01

1a.1

Additional Mammographic
Views

259

259 1. Yes
2. No

Range check. See edit guideline for range checks at the
end of this document.

10.02

1a3

Ultrasound

260

260 1. Yes
2. No

Range check.

Film Comparison to evaluate
an Assessment Incomplete

261

261 1. Yes
2. No/Not Applicable

Range check.

10.03

Code ‘1’ (Yes) if film comparison was done when required
to further evaluate an Initial Mammogram Test Result as
Assessment Incomplete (6.05 = 6 or 13); otherwise, code
‘2’ (No/Not Applicable) if film comparison was not done or
done as part of standard imaging evaluation.
Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
10.04

Final Imaging Outcome

262

262 1. Negative (BI-RADS 1)
2. Benign Finding (BI-RADS 2)
3. Probably Benign - Short interval follow-up indicated
(BI-RADS 3)
4. Suspicious Abnormality - Biopsy should be considered
(BI-RADS 4)
5. Highly Suggestive of Malignancy - Appropriate action should be
taken (BI-RADS 5)
7. Unsatisfactory - This applies if the additional imaging result was
technically unsatisfactory and final assessment could not be
made.
8. Additional imaging pending

Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
This is the assessment from all imaging procedures,
including comparison with previous films, needed to arrive
at a final outcome. Assessment incomplete is NOT an
option; however, if programs experience a delay in
receiving comparison films or additional imaging results
they should report ’8’ (Additional imaging pending).
If no additional breast imaging procedures (10.01 through
10.03) were performed, this field should be left blank.
If at least one procedure was planned, but patient refused
the procedure, or was lost to follow-up prior to its
completion, please indicate this in “Status of Final
Diagnosis/Imaging” (12.01).

Version 6.0
12/04/2007

Item Number
New

Old

10.05

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

Date of Final Imaging
Outcome

263

270 If Final Imaging Outcome (10.04) < ‘5’ or ‘7’, enter MMDDYYYY.
If Final Imaging Outcome (10.04) = ‘8’ blank fill.

Edit Checks/Skip Patterns
Data collection for this field is effective 01/01/2009.
Historical data can be reported if accurately collected;
otherwise, leave blank.
If not blank, must be a valid date and > the “Date of Initial
Mammogram” (6.06) if known. Check the skip pattern.
If additional imaging is performed on more than one date,
report the date of the last procedure used to determine a
final imaging outcome.

11. Breast Diagnostic Procedures
11.01

1a.2

Repeat Breast Exam/
Surgical Consultation

271

271 1. Yes
2. No

Range check.

11.02

1a.4

Biopsy/Lumpectomy

272

272 1. Yes
2. No

Range check.

11.03

1a.5

Fine Needle/Cyst Aspiration

273

273 1. Yes
2. No

Range check.

11.04

1a.6

Other Breast Procedures
Performed

274

274 1. Yes
2. No

Range check.

11.05

1a.6

Other Breast Procedures
Performed Description
(from 11.04)

275

314 Free text format, Description of "Other Breast Procedures
Performed"

Check the skip pattern. See edit guideline for skip
patterns at the end of this document.

11.06

1a.7

Additional Breast Procedures
Paid by NBCCEDP Funds

315

315 1. Yes
2. No
3. Unknown

If at least one of the additional breast procedures was
paid by NBCCEDP Funds, then this field should be set to
‘1’ (Yes).

Version 6.0
12/04/2007

Item Number
New

Old

Column
Variable Name

Codes / Format / Comments

Length

Begin

End

316

316 1. Work-up complete
2. Work-up pending
3. Lost to follow-up
4. Work-up refused
9. Irreconcilable

Edit Checks/Skip Patterns

12. Breast Final Diagnosis Information
12.01

Status of Final
Diagnosis / Imaging

Range check.
A status of “Work-up complete” means that all additional
imaging and diagnostic testing (if applicable) is complete,
and that the “Final Diagnosis” (12.02) and “Date of Final
Diagnosis” (12.03) are known.

A response of ’9’ will be used for those, which after clinical review;
it is determined that there is no sufficient way to translate the
clinical scenario into the MDE data record. An example would be:
If the clinician refers the woman for short-term follow-up instead of
following the guideline for immediate diagnostic work-up, enter a ‘9’
to indicate a closed cycle with an irreconcilable status.
12.02

Final Diagnosis

317

317 1. Carcinoma In Situ, Other*
2. Invasive Breast Cancer
3. Breast Cancer Not Diagnosed
4. Lobular Carcinoma In Situ (LCIS) - (Stage 0)
5. Ductal Carcinoma In Situ (DCIS ) - (Stage 0)

Range check.
If a patient gets additional imaging procedures and a Final
Imaging Outcome that requires no further diagnostic
procedures, then this field should be coded as ‘3’ (Breast
Cancer Not Diagnosed).

*Category (1) - CIS, Other is not a current reporting option for Final
Diagnosis. It was used to report CIS diagnoses prior to
10/01/1999.
12.03

Date of Final
Diagnosis / Imaging

318

325

If Status of Final Diagnosis/Imaging = ‘1’, then enter
MMDDYYYY, the date of diagnosis of cancer or date that
decision made that no cancer present.

Check the skip pattern. If not blank, should be > “Date of
Initial Mammogram” (6.06) or “Clinical Breast Exam Date”
(4.03) in All Patients Section. See edit guidelines for
dates at the end of this document.

If Status of Final Diagnosis/Imaging = ‘2’, then blank fill.
If Status of Final Diagnosis/Imaging = ‘3’, ‘4’ or ‘9’ then enter
MMDDYYYY, the administrative date of closeout of this episode.

If only additional imaging was performed [10.01, 10.02, or
10.03 = ‘1’ (Yes)] then this date should be the same as
“Date of Final Imaging Outcome” (10.05). If any
additional “non-imaging” procedures were performed, the
“Date of Final Diagnosis/Imaging” (10.05) should be the
date of the definitive procedure indicating cancer or not
cancer.

Version 6.0
12/04/2007

Item Number

Column

New

Old

Variable Name

Length

Begin

End

12.04

1b2a

Stage at Diagnosis

326

LEGACY DATA ONLY.
This section is used to
report stage data on all
cancer records with initial
screens prior to 1/1/2004;
or stage data not acquired
through state cancer
registries.
Use Section 15 to report
cancer data acquired
through state cancer
registries for screens
dating from 1/1/2004.
12.05

1b2b

Tumor Size
LEGACY DATA ONLY.
This section is used to
report stage data on all
cancer records with initial
screens prior to 1/1/2004;
or stage data not acquired
through state cancer
registries.

Codes / Format / Comments
If Final Diagnosis is a ‘2’ (Invasive Breast Cancer) then enter
one of the following:
1. AJCC Stage I
2. AJCC Stage II
3. AJCC Stage III
4. AJCC Stage IV
5. Summary Local
6. Summary Regional
7. Summary Distant
8. Unknown/Unstaged
If Final Diagnosis is a ‘1’, ‘3’, ‘4’ or ‘5’ then blank fill.

327

If Final Diagnosis is a ‘2’ (Invasive Breast Cancer) then enter
one of the following:
1. 0 to < 1 cm
2. > 1 to < 2 cm
3. > 2 to < 5 cm
4. > 5 cm
5. Unknown

Edit Checks/Skip Patterns
Range and skip pattern check.
This field is not intended for use for breast screens
beginning 01/01/2009 when it is superseded by Registry
Data fields (15.01 – 15.11). However, it may be optionally
reported, in addition to required registry fields, for data
collected from providers.
The staging data should be reported using pathological
stage, which includes clinical staging information,
according to AJCC, Fifth Edition, 1997. AJCC staging
may be reported as pathological or clinical stage. AJCC
stage (pathological or clinical) is preferred over summary
stage.

Range and skip pattern check.
This field is not intended for use for breast screens
beginning 01/01/2009 when it is superseded by Registry
Data fields (15.01 – 15.11). However, it may be optionally
reported, in addition to required registry fields, for data
collected from providers.

If Final Diagnosis is a ‘1’, ‘3’, ‘4’ or ‘5’ then blank fill.

Use Section 15 to report
cancer data acquired
through state cancer
registries for screens
dating from 1/1/2004.

Version 6.0
12/04/2007

Item Number
New

Old

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

Edit Checks/Skip Patterns

13. Breast Cancer Treatment Information – This section is completed based on the results of Final Diagnosis (12.02).
13.01

Status of Treatment

328

328 If Final Diagnosis (12.02) = ‘1’, ‘2’ or ‘5’ then complete 13.01 and
13.02.
If Final Diagnosis (12.02) = ‘4’, then 13.01 and 13.02 MAY be
completed.
If Final Diagnosis (12.02) = ‘3’, then 13.01 and 13.02 should be
blank.
1. Treatment started
2. Treatment pending
3. Lost to follow-up
4. Treatment refused
5. Treatment not needed

Range and skip pattern check.
A woman should be classified as having started treatment
when the Program has confirmed that a plan for treatment
of the cancer or precancerous lesion has been developed
and started.

If a woman dies before treatment has started, enter a ‘3’ (Lost to
follow-up).
13.02

Date of Treatment Status

329

336 If Status of Treatment (13.01) = ‘1’, then enter MMDDYYYY, the
date that treatment for cancer began.
If Status of Treatment (13.01) = ‘2’, then blank fill.
If Status of Treatment (13.01) = ‘3’, ‘4’, or ‘5’ then enter
MMDDYYYY, the date of administrative closeout.

Check the skip pattern. If not blank, should be > “Date of
Final Diagnosis” (12.03).

Reserved

337

341 Reserved for future use.

This field should be blank filled.

Version 6.0
12/04/2007

Item Number
New

Old

Column
Variable Name

Length

Begin

Codes / Format / Comments

End

Edit Checks/Skip Patterns

14. Cervical Cancer Registry Data – If Final Diagnosis (8.02) is a ‘6’ (Invasive Cervical Carcinoma) and the patient was screened as of January 1, 2004, then this section must be
completed. This section is reserved for data acquired through a State Central Cancer Registry or an equivalent data source approved by CDC/IMS.
NAACCR Record Data Standards and Data Dictionary are available at www.naaccr.org.
14.01

Registry Linkage Status

342

342 1. Linkage process pending
2. Linkage process complete, record matched
3. Linkage process attempted, record not matched

Range check.

14.02

Registry Date of Diagnosis

343

350 MMDDYYYY

Leave blank if 14.01 = 1, 3.

[NAACCR data item #390]
14.03

Registry Histologic Type

If not blank, must be a valid date.
4

351

[NAACCR data item #522]

354 Range: 8000-9758

Range check.

Valid values for Histologic Type include: 8000-8082, 8070-8084,
Leave blank if 14.01 = 1, 3.
8120-8124, 8140-8147, 8200, 8201, 8255-8263, 8310, 8323, 8384,
8430, 8480-8482, 8560, 8562, 8570-8575, 8800-8815, 8890, 8912,
8950, 8951, 8980-8991, 9110, 9590-9596, 9650-9758.
A complete list of valid values/labels will be provided for reference
in the Field Description section of the Data User’s Manual.

14.04

Registry Behavior

355

[NAACCR data item #523]

14.05

Registry Summary Stage
[NAACCR data item:
#3020 When 14.02 >
1/1/2004
#759 When 14.02 =
1/1/2001 – 12/31/2003
#760 When 14.02 <
12/31/2000]

356

355 0. Benign
1. Uncertain whether benign or malignant/Borderline malignancy
2. Carcinoma In Situ
3. Malignant

Range check.

356 0. In situ (IS)
1. Localized (L)
2. Regional, direct extension only (RE)
3. Regional, regional lymph nodes only (RN)
4. Regional, extension and nodes (RE+RN)
5. Regional, NOS (RNOS)
7. Distant (D)
8. Not Applicable (NA)
9. Unknown/unstaged (U)

Range check.

Leave blank if 14.01 = 1, 3.

Leave blank if 14.01 = 1, 3.
Note: These NAACCR data items are specific to
definitions in place for the calendar year of the Registry
Date of Diagnosis (14.02).

Version 6.0
12/04/2007

Item Number
New
14.06

Old

Column
Variable Name

Length

Begin

End

Registry Collaborative Stage
(CS) – Derived AJCC Stage
Group

357

358 Range: 00-99

Registry Collaborative Stage
(CS) Tumor Size

Edit Checks/Skip Patterns
Range check.

Valid values for CS-derived AJCC stage include: 00-02, 10-24, 30- Leave blank if 14.01 = 1, 3.
43, 50-63, 70-74, 88, 90, 99.
Complete only if Registry Date of Diagnosis (14.02) >
A complete list of valid values/labels will be provided for reference 01/01/2004; otherwise leave blank.
in the Field Description section of the Data User’s Manual.

[NAACCR data item #3000]

14.07

Codes / Format / Comments

359

361 If Final Diagnosis is a ‘6’ (Invasive Cervical Carcinoma) then enter
one of the following:

Range check.
Leave blank if 14.01 = 1, 3.

[NAACCR data item #2800]

001-988 Exact size in millimeters
989. > 989 millimeters
990. Microscopic focus or foci only; no size of focus is given
991. Described as less than 1 cm
992. Described as less than 2 cm
993. Described as less than 3 cm
994. Described as less than 4 cm
995. Described as less than 5 cm
999. Unknown; size not stated

Complete only if Registry Date of Diagnosis (14.02) >
01/01/2004; otherwise leave blank.

If Final Diagnosis is ‘1’, ‘2’, ‘3’, ‘4’, ‘5’, ‘7’, ‘8’ or ‘9’, leave blank.
See most current version of the CS Staging Manual:
http://www.cancerstaging.org/cstage/manuals.html
v01.03.00 (Sept 2006), Part I, pg 25
14.08

Registry Collaborative Stage
(CS) Extension
[NAACCR data item #2810]

362

363 Range: 00 – 99
Valid values for CS extension include: 00, 01, 11, 12, 20, 25, 30,
31, 35, 36, 37, 38, 39, 40, 50, 60, 62, 63, 65, 68, 70, 80, 95, 99.
A complete list of valid values/labels will be provided for reference
in the Field Description section of the Data User’s Manual.

Range check.
Leave blank if 14.01 = 1, 3.
Complete only if Registry Date of Diagnosis (14.02) >
01/01/2004; otherwise leave blank.

See most current version of the CS Staging Manual:
http://www.cancerstaging.org/cstage/manuals.html
v01.03.00 (Sept 2006), Part II, pg 389

Version 6.0
12/04/2007

Item Number
New
14.09

Old

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

Registry Collaborative Stage
(CS) Lymph Nodes

364

365 Range 00 – 99

Edit Checks/Skip Patterns
Range check.

Valid values for CS lymph nodes include: 00, 10, 80, 99.

Leave blank if 14.01 = 1, 3.

A complete list of valid values/labels will be provided for reference
in the Field Description section of the Data User’s Manual.

Complete only if Registry Date of Diagnosis (14.02) >
01/01/2004; otherwise leave blank.

[NAACCR data item #2830]

See most current version of the CS Staging Manual:
http://www.cancerstaging.org/cstage/manuals.html
v01.03.00 (Sept 2006), Part II, pg 391
14.10

Registry Collaborative Stage
(CS) Mets at Diagnosis

366

367 Range 00 – 99

Range check.

Valid values for CS mets at diagnosis include: 00, 10, 40, 50, 99.

Leave blank if 14.01 = 1, 3.

A complete list of valid values/labels will be provided for reference
in the Field Description section of the Data User’s Manual.

Complete only if Registry Date of Diagnosis (14.02) >
01/01/2004; otherwise leave blank.

[NAACCR data item #2850]

See most current version of the CS Staging Manual:
http://www.cancerstaging.org/cstage/manuals.html
v01.03.00 (Sept 2006), Part II, pg 392
14.11

Registry Primary Site
[NAACCR data item #400]

368

371 C000 – C999

Range check.

NOTE: The ‘C’ must be included as part of the variable response in Leave blank if 14.01 = 1, 3.
the MDE file. For example, Endocervix = C530. A complete list of
valid values/labels for this item will be provided for reference in the Complete only if Registry Date of Diagnosis (14.02) >
Data User’s Manual.
01/01/2004; otherwise leave blank.

Version 6.0
12/04/2007

Item Number
New

Old

Column
Variable Name

Length

Begin

Codes / Format / Comments

End

Edit Checks/Skip Patterns

15. Breast Cancer Registry Data – If Final Diagnosis (12.02) is a ‘1’ (Carcinoma In Situ, Other), ‘2’ (Invasive Breast Cancer), ‘4’ (Lobular Carcinoma In Situ) or ‘5’ (Ductal Carcinoma In
Situ) and the patient was screened as of January 1, 2004, then this section must be completed. This section is reserved for data acquired through a State Central Cancer Registry or
an equivalent data source approved by CDC/IMS.
NAACCR Record Data Standards and Data Dictionary are available at www.naaccr.org.
15.01

Registry Linkage Status

372

372 1. Pending linkage
2. Linked, matched
3. Linked, not matched

Range check.

15.02

Registry Date of Diagnosis

373

380 MMDDYYYY

Leave blank if 15.01 = 1, 3.

[NAACCR data item #390]
15.03

Registry Histologic Type

If not blank, must be a valid date.
4

381

[NAACCR data item #522]

384 Range: 8000-9758

Range check.

Valid values for Histologic Type include: 8000-8052, 8070-8078,
Leave blank if 15.01 = 1, 3.
8140-8147, 8190-8261, 8310-8323, 8401, 8440, 8480, 8481, 8491,
8500-8575, 8800-8815, 8885-8858, 8890-8896, 8935, 8980-8982,
8990, 8991, 9020, 9120, 9130, 9133, 9580, 9581, 9590-9596,
9650-9758 .
A complete list of valid values/labels will be provided for reference
in the Field Description section of the Data User’s Manual.

15.04

Registry Behavior

385

[NAACCR data item #523]

15.05

Registry Summary Stage
[NAACCR data item:
#3020 When 15.02 >
1/1/2004
#759 When 15.02 =
1/1/01- 12/31/03
#760 When 15.02 <
12/31/2000]

386

385 0. Benign
1. Uncertain whether benign or malignant/Borderline malignancy
2. Carcinoma In Situ
3. Malignant

Range check.

386 0. In situ (IS)
1. Localized (L)
2. Regional, direct extension only (RE)
3. Regional, regional lymph nodes only (RN)
4. Regional, extension and nodes (RE+RN)
5. Regional, NOS (RNOS)
7. Distant (D)
8. Not Applicable (NA)
9. Unknown/unstaged (U)

Range check.

Leave blank if 15.01 = 1, 3.

Leave blank if 15.01 = 1, 3.
Note: These NAACCR data items are specific to
definitions in place for the calendar year of the Registry
Date of Diagnosis (15.02).

Version 6.0
12/04/2007

Item Number
New
15.06

Old

Column
Variable Name

Length

Begin

End

Registry Collaborative Stage
(CS) – Derived AJCC Stage
group

387

388 Range: 00-99

Registry Collaborative Stage
(CS) Tumor Size

Edit Checks/Skip Patterns
Range check.

Valid values for CS-derived AJCC stage include: 00-02, 10-24, 30- Leave blank if 15.01 = 1, 3.
43, 50-63, 70-74, 88, 90, 99.
Complete only if Registry Date of Diagnosis (15.02) >
A complete list of valid values/labels will be provided for reference 01/01/2004; otherwise leave blank.
in the Field Description section of the Data User’s Manual.

[NAACCR data item #3000]

15.07

Codes / Format / Comments

389

391 If Final Diagnosis is a ‘1’ (Carcinoma In Situ, Other), ‘2’ (Invasive
Breast Cancer), ‘4’ (Lobular Carcinoma In Situ) or ‘5’ (Ductal
Carcinoma In Situ) then enter one of the following:

Range check and skip pattern check.
Leave blank if 15.01 = 1, 3.

[NAACCR data item #2800]
001-988 Exact size in millimeters
989. > 989 millimeters
990. Microscopic focus or foci only; no size of focus is given
991. Described as less than 1 cm
992. Described as between 1 cm and 2 cm
993. Described as between 2 cm and 3 cm
994. Described as between 3 cm and 4 cm
995. Described as between 4 cm and 5 cm
997. Paget’s Disease of nipple with no demonstrable tumor
998. Diffuse
999. Unknown; size not stated

Complete only if Registry Date of Diagnosis (15.02) >
01/01/2004; otherwise leave blank.

If Final Diagnosis is a ‘3’ then blank fill.
See most current version of the CS Staging Manual:
http://www.cancerstaging.org/cstage/manuals.html
v01.03.00 (Sept 2006), Part II, pg 371
15.08

Registry Collaborative Stage
(CS) Extension
[NAACCR data item #2810]

392

393 Range: 00 – 99
Valid values for CS extension include: 00, 05, 07, 10, 20, 30, 40,
51, 52, 61, 62, 71, 72, 73, 95, 99
A complete list of valid values/labels will be provided for reference
in the Field Description section of the Data User’s Manual.

Range check.
Leave blank if 15.01 = 1, 3.
Complete only if Date of Diagnosis (15.02) > 01/01/2004;
otherwise leave blank.

See most current version of the CS Staging Manual:
http://www.cancerstaging.org/cstage/manuals.html
v01.03.00 (Sept 2006), Part II, pg 372

Version 6.0
12/04/2007

Item Number
New
15.09

Old

Column
Variable Name

Length

Begin

End

Codes / Format / Comments

Registry Collaborative Stage
(CS) Lymph Nodes

394

395 Range 00 – 99
Valid values for CS lymph nodes include: 00, 05, 13, 15, 25, 26,
28, 50, 60, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 99.

[NAACCR data item #2830]

A complete list of valid values/labels will be provided for reference
in the Field Description section of the Data User’s Manual.

Edit Checks/Skip Patterns
Range check.
Leave blank if 15.01 = 1, 3.
Complete only if Registry Date of Diagnosis (15.02) >
01/01/2004; otherwise leave blank.

See most current version of the CS Staging Manual:
http://www.cancerstaging.org/cstage/manuals.html
v01.03.00 (Sept 2006), Part II, pg 374
15.10

Registry Collaborative Stage
(CS) Mets at Diagnosis

396

397 Range 00 – 99
Valid values for CS mets at diagnosis include: 00, 10, 40, 42, 44,
50, 99.

[NAACCR data item #2850]

A complete list of valid values/labels will be provided for reference
in the Field Description section of the Data User’s Manual.

Range check.
Leave blank if 15.01 = 1, 3.
Complete only if Registry Date of Diagnosis (15.02) >
01/01/2004; otherwise leave blank.

See most current version of the CS Staging Manual:
http://www.cancerstaging.org/cstage/manuals.html
v01.03.00 (Sept 2006), Part II, pg 376
15.11

Registry Primary Site
[NAACCR data item #400]

398

401 C000 – C999

Range check.

NOTE: The ‘C’ must be included as part of the variable response in Leave blank if 15.01 = 1, 3.
the MDE file. For example, Breast NOS = C509. A complete list of
valid values/labels for this item will be provided for reference in the Complete only if Registry Date of Diagnosis (15.02) >
Data User’s Manual.
01/01/2004; otherwise leave blank.

Version 6.0
12/04/2007

99. End of Record Mark – Completed for each MDE record
End of Record/Newline

402

402 Character that ends the current record and begins a new line of
text.

Example: Carriage Return-Line Feed

General edit guidelines for:
Dates: If your data processing system does not store dates as complete dates (i.e. they are separate month, day, and year fields), you need to verify the individual fields. The month needs to be between 1 and 12 and the
day, if specified, between 1 and 31 and appropriate for the month (i.e. no June 31). A common situation for some dates could be that the year is known, but the month or day is not. If this occurs, please blank fill only the
unknown fields.
Correct date sequences: A correct sequence of dates that track screening, diagnosis, and treatment is very important. These relationships have been specified in the edit section above. Please check these date
relationships to ensure that the date sequences are reasonable.
Range checks: These are performed on fields like Hispanic Origin (3.05), Race (3.06.x), Breast Symptoms (4.01), etc. where specific values are requested. A simple check of these data before they are submitted will
ensure that, for example, Hispanic Origin only has values of ‘1’ to ‘3’ as specified in the MDE documentation.
Skip patterns: There are fields in the MDEs that are supposed to be completed under certain circumstances and left blank in others. For example, Clinical Breast Exam Date (4.03) should only be completed if Clinical
Breast Exam (4.02) is a ‘1’ or ‘2’. Thus please check to see that if, for example, 10 women have a ‘1’ or a ‘2’ for Clinical Breast Exam, that there are no more than 10 Clinical Breast Exam Dates (4.03).

Version 6.0
12/04/2007

File Type	application/pdf
File Title	National Breast and Cervical Cancer Early Detection Program
Author	Mattingl
File Modified	2008-03-17
File Created	2008-03-17